940 related articles for article (PubMed ID: 33724184)
21. Randomized controlled trials in pregnancy: scientific and ethical aspects. Exposure to different opioid medications during pregnancy in an intra-individual comparison.
Unger A; Jagsch R; Jones H; Arria A; Leitich H; Rohrmeister K; Aschauer C; Winklbaur B; Bäwert A; Fischer G
Addiction; 2011 Jul; 106(7):1355-62. PubMed ID: 21438938
[TBL] [Abstract][Full Text] [Related]
22. Delayed villous maturation in term placentas exposed to opioid maintenance therapy: a retrospective cohort study.
Serra AE; Lemon LS; Mokhtari NB; Parks WT; Catov JM; Venkataramanan R; Caritis SN
Am J Obstet Gynecol; 2017 Apr; 216(4):418.e1-418.e5. PubMed ID: 28024988
[TBL] [Abstract][Full Text] [Related]
23. Cognitive Outcomes of Young Children After Prenatal Exposure to Medications for Opioid Use Disorder: A Systematic Review and Meta-analysis.
Nelson LF; Yocum VK; Patel KD; Qeadan F; Hsi A; Weitzen S
JAMA Netw Open; 2020 Mar; 3(3):e201195. PubMed ID: 32186745
[TBL] [Abstract][Full Text] [Related]
24. Perturbed neurochemical and microstructural organization in a mouse model of prenatal opioid exposure: A multi-modal magnetic resonance study.
Shahid SS; Grecco GG; Atwood BK; Wu YC
PLoS One; 2023; 18(7):e0282756. PubMed ID: 37471385
[TBL] [Abstract][Full Text] [Related]
25. Changing Outdated Methadone Regulations That Harm Pregnant Patients.
McCarthy JJ; Jones HE; Terplan M; Rudolf VP; von Klimo MC
J Addict Med; 2021 Apr; 15(2):93-95. PubMed ID: 32826620
[TBL] [Abstract][Full Text] [Related]
26. Transitioning from methadone to buprenorphine maintenance in management of opioid use disorder during pregnancy.
Johnson S; Martin PR
Am J Drug Alcohol Abuse; 2018; 44(3):310-316. PubMed ID: 28829626
[TBL] [Abstract][Full Text] [Related]
27. Treatment of opioid dependence in the setting of pregnancy.
Young JL; Martin PR
Psychiatr Clin North Am; 2012 Jun; 35(2):441-60. PubMed ID: 22640765
[TBL] [Abstract][Full Text] [Related]
28. Evidence for the Normalization Effects of Medication for Opioid Use Disorder on Functional Connectivity in Neonates with Prenatal Opioid Exposure.
Liu J; Grewen K; Gao W
J Neurosci; 2022 Jun; 42(22):4555-4566. PubMed ID: 35552232
[TBL] [Abstract][Full Text] [Related]
29. A Retrospective Cohort Study of Birth Outcomes in Neonates Exposed to Naltrexone in Utero: A Comparison with Methadone-, Buprenorphine- and Non-opioid-Exposed Neonates.
Kelty E; Hulse G
Drugs; 2017 Jul; 77(11):1211-1219. PubMed ID: 28536981
[TBL] [Abstract][Full Text] [Related]
30. Gestational buprenorphine exposure: Effects on pregnancy, development, neonatal opioid withdrawal syndrome, and behavior in a translational rodent model.
Wallin CM; Bowen SE; Roberge CL; Richardson LM; Brummelte S
Drug Alcohol Depend; 2019 Dec; 205():107625. PubMed ID: 31706250
[TBL] [Abstract][Full Text] [Related]
31. Buprenorphine-naloxone, buprenorphine, and methadone throughout pregnancy in maternal opioid use disorder.
Kanervo MM; Tupola SJ; Nikkola EM; Rantakari KM; Kahila HK
Acta Obstet Gynecol Scand; 2023 Mar; 102(3):313-322. PubMed ID: 36562462
[TBL] [Abstract][Full Text] [Related]
32. Hospitalization of children after prenatal exposure to opioid maintenance therapy during pregnancy: a national registry study from the Czech Republic.
Skurtveit S; Nechanská B; Handal M; Mahic M; Mravčík V; Gabrhelík R
Addiction; 2019 Jul; 114(7):1225-1235. PubMed ID: 30725515
[TBL] [Abstract][Full Text] [Related]
33. Pharmacological treatment of opioid use disorder in pregnancy.
Rodriguez CE; Klie KA
Semin Perinatol; 2019 Apr; 43(3):141-148. PubMed ID: 30755340
[TBL] [Abstract][Full Text] [Related]
34. Association between prenatal tobacco exposure and outcome of neonates born to opioid-maintained mothers. Implications for treatment.
Winklbaur B; Baewert A; Jagsch R; Rohrmeister K; Metz V; Aeschbach Jachmann C; Thau K; Fischer G
Eur Addict Res; 2009; 15(3):150-6. PubMed ID: 19420947
[TBL] [Abstract][Full Text] [Related]
35. Exposure to prescription opioid analgesics in utero and risk of neonatal abstinence syndrome: population based cohort study.
Desai RJ; Huybrechts KF; Hernandez-Diaz S; Mogun H; Patorno E; Kaltenbach K; Kerzner LS; Bateman BT
BMJ; 2015 May; 350():h2102. PubMed ID: 25975601
[TBL] [Abstract][Full Text] [Related]
36. Methadone during pregnancy: the search for a valid animal model.
Hutchings DE; Zmitrovich A; Church S; Malowany D
Ann Ist Super Sanita; 1993; 29(3):439-44. PubMed ID: 8172463
[TBL] [Abstract][Full Text] [Related]
37. Behavioral effects of perinatal opioid exposure.
Fodor A; Tímár J; Zelena D
Life Sci; 2014 May; 104(1-2):1-8. PubMed ID: 24746901
[TBL] [Abstract][Full Text] [Related]
38. Variations in Infant CYP2B6 Genotype Associated with the Need for Pharmacological Treatment for Neonatal Abstinence Syndrome in Infants of Methadone-Maintained Opioid-Dependent Mothers.
Mactier H; McLaughlin P; Gillis C; Osselton MD
Am J Perinatol; 2017 Jul; 34(9):918-921. PubMed ID: 28320034
[No Abstract] [Full Text] [Related]
39. Neonatal outcomes after fetal exposure to methadone and buprenorphine: national registry studies from the Czech Republic and Norway.
Nechanská B; Mravčík V; Skurtveit S; Lund IO; Gabrhelík R; Engeland A; Handal M
Addiction; 2018 Jul; 113(7):1286-1294. PubMed ID: 29443414
[TBL] [Abstract][Full Text] [Related]
40. Prenatal opioid administration induces shared alterations to the maternal and offspring gut microbiome: A preliminary analysis.
Grecco GG; Gao Y; Gao H; Liu Y; Atwood BK
Drug Alcohol Depend; 2021 Oct; 227():108914. PubMed ID: 34364194
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
